Interactions between radiation and endocrine therapy in breast cancer - PubMed (original) (raw)
Review
Interactions between radiation and endocrine therapy in breast cancer
H Schmidberger et al. Endocr Relat Cancer. 2003 Sep.
Abstract
Adjuvant radiotherapy and adjuvant endocrine therapy are commonly given to patients with invasive breast cancer or with ductal carcinoma in situ (DCIS). Although both therapies have been well established through a number of randomized studies, little is known about a possible interaction of both treatment modalities if they are given simultaneously. A number of in vitro studies have indicated that tamoxifen treatment might reduce the intrinsic radiosensitivity of MCF-7 breast cancer cells. Conversely, estradiol treatment increases the intrinsic radiosensitivity of MCF-7 cells. In one available animal study, an antagonistic effect of tamoxifen and ionizing radiation (XRT) could not be observed. Retrospective analyses of randomized clinical studies have not indicated an antagonistic effect of tamoxifen on the effectiveness of XRT, since local control has been consistently higher when XRT was combined with tamoxifen, compared with treatment with XRT alone, regardless of whether tamoxifen was started simultaneously with radiotherapy or after completion of radiotherapy. Currently there are no clinical data available that would suggest an adverse effect of adjuvant tamoxifen treatment started prior to or simultaneously with radiotherapy in breast cancer or DCIS. However, since an antagonistic effect of tamoxifen and simultaneous chemotherapy has been reported recently, the issue of simultaneous versus sequential radiation and tamoxifen treatment in breast cancer should be addressed in further studies.
Similar articles
- Combination of anti-estrogenic therapy with radiation in breast cancer: simultaneous or sequential treatment?
Schmidberger H, Hermann RM, Hess CF, Emons G. Schmidberger H, et al. Onkologie. 2005 May;28(5):275-80. doi: 10.1159/000085153. Epub 2005 Apr 29. Onkologie. 2005. PMID: 15867485 - Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less.
Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S, Pisansky TM, Wolmark N; National Surgical Adjuvant Breast and Bowel Project. Fisher B, et al. J Clin Oncol. 2002 Oct 15;20(20):4141-9. doi: 10.1200/JCO.2002.11.101. J Clin Oncol. 2002. PMID: 12377957 Clinical Trial. - [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
Sautter-Bihl ML. Sautter-Bihl ML. Strahlenther Onkol. 1999 Dec;175(12):620-1. Strahlenther Onkol. 1999. PMID: 10633790 German. No abstract available. - Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis.
Staley H, McCallum I, Bruce J. Staley H, et al. Breast. 2014 Oct;23(5):546-51. doi: 10.1016/j.breast.2014.06.015. Epub 2014 Jul 9. Breast. 2014. PMID: 25023044 Review.
Cited by
- The many facets of Notch signaling in breast cancer: toward overcoming therapeutic resistance.
Nandi A, Chakrabarti R. Nandi A, et al. Genes Dev. 2020 Nov 1;34(21-22):1422-1438. doi: 10.1101/gad.342287.120. Genes Dev. 2020. PMID: 33872192 Free PMC article. Review. - Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer.
Jin Y, Choi YJ, Heo K, Park SJ. Jin Y, et al. Int J Mol Sci. 2021 Jan 4;22(1):438. doi: 10.3390/ijms22010438. Int J Mol Sci. 2021. PMID: 33406787 Free PMC article. Review. - Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review.
Ding J, Guo Y, Jiang X, Li K, Fu W, Cao Y. Ding J, et al. Medicine (Baltimore). 2020 Jul 24;99(30):e21344. doi: 10.1097/MD.0000000000021344. Medicine (Baltimore). 2020. PMID: 32791733 Free PMC article. - Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study.
Kang YM, Chao TF, Wang TH, Hu YW. Kang YM, et al. Cancer Med. 2019 Jul;8(8):3639-3647. doi: 10.1002/cam4.2030. Epub 2019 May 18. Cancer Med. 2019. PMID: 31104362 Free PMC article. - Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.
Bourgier C, Castan F, Riou O, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Gourgou S, Brengues M, Fenoglietto P, Ozsahin EM, Azria D. Bourgier C, et al. Oncotarget. 2018 Mar 2;9(21):15757-15765. doi: 10.18632/oncotarget.24606. eCollection 2018 Mar 20. Oncotarget. 2018. PMID: 29644007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical